Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (right eye)
ICD-10 E09.3551 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (right eye).
E09.3551 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to complications such as proliferative diabetic retinopathy in the right eye. This condition arises when certain medications or substances disrupt normal glucose metabolism, resulting in hyperglycemia and subsequent diabetes. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to vision impairment. The term 'stable' indicates that the retinopathy has not progressed or worsened, suggesting that the patient is under effective management. Management of this condition typically involves monitoring blood glucose levels, maintaining HbA1c levels below 7%, and possibly insulin therapy to control diabetes. Regular ophthalmologic evaluations are crucial to monitor the status of the retinopathy and prevent further complications.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes due to medication, management of insulin therapy.
Ensure clear documentation of the drug responsible for diabetes and its management.
Visual acuity tests, retinal examination findings, and treatment plans.
Patients with diabetic retinopathy requiring laser treatment or monitoring.
Document the stability of retinopathy and any interventions performed.
Used for follow-up visits for diabetes management.
Document patient's diabetes management, medication adjustments, and HbA1c levels.
Endocrinologists should ensure comprehensive diabetes management documentation.
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin secretion or action.
